Literature DB >> 23986515

CXCR2 knockout mice are protected against DSS-colitis-induced acute kidney injury and inflammation.

Punithavathi Ranganathan1, Calpurnia Jayakumar, Santhakumar Manicassamy, Ganesan Ramesh.   

Abstract

Organ cross talk exists in many diseases of the human and animal models of human diseases. A recent study demonstrated that inflammatory mediators can cause acute kidney injury and neutrophil infiltration in a mouse model of dextran sodium sulfate (DSS)-colitis. However, the chemokines and their receptors that may mediate distant organ effects in colitis are unknown. We hypothesized that keratinocyte chemoattractant (KC)/IL-8 receptor chemokine (C-X-C motif) ligand 2 (CXCL2) mediates DSS-colitis-induced acute kidney injury. Consistent with our hypothesis, wild-type (WT) mice developed severe colitis with DSS treatment, which was associated with inflammatory cytokine and chemokine expression and neutrophil infiltration in the colon. DSS-colitis in WT was accompanied by acute kidney injury and enhanced expression of inflammatory cytokines in the kidney. However, CXCR2 knockout mice were protected against DSS-colitis as well as acute kidney injury. Moreover, the expression of cytokines and chemokines and neutrophil infiltration was blunted in CXCR2 knockout mice in the colon and kidney. Administration of recombinant KC exacerbated DSS-colitis-induced acute kidney injury. Our results suggest that KC/IL-8 and its receptor CXCR2 are critical and major mediators of organ cross talk in DSS colitis and neutralization of CXCR2 will help to reduce the incidence of acute kidney injury due to ulcerative colitis and Crohn's disease in humans.

Entities:  

Keywords:  CXCR2; KC; acute kidney; colitis; inflammation

Mesh:

Substances:

Year:  2013        PMID: 23986515      PMCID: PMC3840251          DOI: 10.1152/ajprenal.00319.2013

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  28 in total

1.  Tubulointerstitial disease and ulcerative colitis.

Authors:  Hamid T Khosroshahi; Mohammadali Mohajel Shoja
Journal:  Nephrol Dial Transplant       Date:  2006-04-20       Impact factor: 5.992

2.  NKT cell activation mediates neutrophil IFN-gamma production and renal ischemia-reperfusion injury.

Authors:  Li Li; Liping Huang; Sun-sang J Sung; Peter I Lobo; Michael G Brown; Randal K Gregg; Victor H Engelhard; Mark D Okusa
Journal:  J Immunol       Date:  2007-05-01       Impact factor: 5.422

3.  American gastroenterological association consensus development conference on the use of biologics in the treatment of inflammatory bowel disease, June 21-23, 2006.

Authors:  Michael Clark; Jean-Frederic Colombel; Brian C Feagan; Richard N Fedorak; Stephen B Hanauer; Michael A Kamm; Lloyd Mayer; Carol Regueiro; Paul Rutgeerts; William J Sandborn; Bruce E Sands; Stefan Schreiber; Stephan Targan; Simon Travis; Severine Vermeire
Journal:  Gastroenterology       Date:  2007-07       Impact factor: 22.682

Review 4.  Renal and urologic complications of inflammatory bowel disease.

Authors:  D S Pardi; W J Tremaine; W J Sandborn; J T McCarthy
Journal:  Am J Gastroenterol       Date:  1998-04       Impact factor: 10.864

5.  Chronic experimental colitis induced by dextran sulphate sodium (DSS) is characterized by Th1 and Th2 cytokines.

Authors:  L A Dieleman; M J Palmen; H Akol; E Bloemena; A S Peña; S G Meuwissen; E P Van Rees
Journal:  Clin Exp Immunol       Date:  1998-12       Impact factor: 4.330

6.  Accumulation, activation, and survival of neutrophils in ulcerative colitis: regulation by locally produced factors in the colon and impact of steroid treatment.

Authors:  Maria Lampinen; Per Sangfelt; Yesuf Taha; Marie Carlson
Journal:  Int J Colorectal Dis       Date:  2008-07-02       Impact factor: 2.571

7.  Effects of epithelial and neutrophil CXCR2 on innate immunity and resistance to kidney infection.

Authors:  M Svensson; H Irjala; C Svanborg; G Godaly
Journal:  Kidney Int       Date:  2008-04-09       Impact factor: 10.612

8.  The chemokine receptors CCR2 and CX3CR1 mediate monocyte/macrophage trafficking in kidney ischemia-reperfusion injury.

Authors:  Li Li; Liping Huang; Sun-Sang J Sung; Amy L Vergis; Diane L Rosin; C Edward Rose; Peter I Lobo; Mark D Okusa
Journal:  Kidney Int       Date:  2008-10-08       Impact factor: 10.612

9.  Crucial pathophysiological role of CXCR2 in experimental ulcerative colitis in mice.

Authors:  Pasquale Buanne; Emma Di Carlo; Lorenzo Caputi; Laura Brandolini; Marco Mosca; Franca Cattani; Luigi Pellegrini; Leda Biordi; Gino Coletti; Carlo Sorrentino; Guido Fedele; Francesco Colotta; Gabriella Melillo; Riccardo Bertini
Journal:  J Leukoc Biol       Date:  2007-07-26       Impact factor: 4.962

10.  The selective nonpeptide CXCR2 antagonist SB225002 ameliorates acute experimental colitis in mice.

Authors:  Allisson Freire Bento; Daniela Ferraz Pereira Leite; Rafaela Franco Claudino; Daniela Balz Hara; Paulo César Leal; João B Calixto
Journal:  J Leukoc Biol       Date:  2008-07-24       Impact factor: 4.962

View more
  31 in total

1.  SIRT2 Regulates LPS-Induced Renal Tubular CXCL2 and CCL2 Expression.

Authors:  Yu Jin Jung; Ae Sin Lee; Tung Nguyen-Thanh; Dal Kim; Kyung Pyo Kang; Sik Lee; Sung Kwang Park; Won Kim
Journal:  J Am Soc Nephrol       Date:  2014-10-27       Impact factor: 10.121

2.  MyD88 mediates the protective effects of probiotics against the arteriolar thrombosis and leukocyte recruitment associated with experimental colitis.

Authors:  Daniele G Souza; Elena Y Senchenkova; Janice Russell; D Neil Granger
Journal:  Inflamm Bowel Dis       Date:  2015-04       Impact factor: 5.325

3.  Effects of Pristine C60 Fullerenes on Liver and Pancreas in α-Naphthylisothiocyanate-Induced Cholangitis.

Authors:  Halyna M Kuznietsova; Natalia V Dziubenko; Oksana V Lynchak; Tetyana S Herheliuk; Dmytro K Zavalny; Olga V Remeniak; Yuriy I Prylutskyy; Uwe Ritter
Journal:  Dig Dis Sci       Date:  2019-07-16       Impact factor: 3.199

4.  Genetic Deletion of LRP5 and LRP6 in Macrophages Exacerbates Colitis-Associated Systemic Inflammation and Kidney Injury in Response to Intestinal Commensal Microbiota.

Authors:  Indumathi Manoharan; Daniel Swafford; Arulkumaran Shanmugam; Nikhil Patel; Puttur D Prasad; Riyaz Mohamed; Qingqing Wei; Zheng Dong; Muthusamy Thangaraju; Santhakumar Manicassamy
Journal:  J Immunol       Date:  2022-06-27       Impact factor: 5.426

5.  Functional characterization of CXCR4 in mediating the expression of protein C system in experimental ulcerative colitis.

Authors:  Xuhong Lin; Huichao Wang; Yuxia Li; Jingnan Yang; Ruilin Yang; Dandan Wei; Junjie Zhang; Desheng Yang; Bin Wang; Xuequn Ren; Guanchang Cheng
Journal:  Am J Transl Res       Date:  2017-11-15       Impact factor: 4.060

6.  Autophagy deficiency in myeloid cells increases susceptibility to obesity-induced diabetes and experimental colitis.

Authors:  Hae-Youn Lee; Jinyoung Kim; Wenying Quan; June-Chul Lee; Min-Soo Kim; Seok-Hyung Kim; Jin-Woo Bae; Kyu Yeon Hur; Myung-Shik Lee
Journal:  Autophagy       Date:  2016-06-23       Impact factor: 16.016

7.  Fish Sidestream-Derived Protein Hydrolysates Suppress DSS-Induced Colitis by Modulating Intestinal Inflammation in Mice.

Authors:  Maria G Daskalaki; Konstantinos Axarlis; Tone Aspevik; Michail Orfanakis; Ourania Kolliniati; Ioanna Lapi; Maria Tzardi; Eirini Dermitzaki; Maria Venihaki; Katerina Kousoulaki; Christos Tsatsanis
Journal:  Mar Drugs       Date:  2021-05-28       Impact factor: 5.118

8.  Giardia duodenalis infection reduces granulocyte infiltration in an in vivo model of bacterial toxin-induced colitis and attenuates inflammation in human intestinal tissue.

Authors:  James A Cotton; Jean-Paul Motta; L Patrick Schenck; Simon A Hirota; Paul L Beck; Andre G Buret
Journal:  PLoS One       Date:  2014-10-07       Impact factor: 3.240

9.  A20 regulates IL-1-induced tolerant production of CXC chemokines in human mesangial cells via inhibition of MAPK signaling.

Authors:  Hongbo Luo; Yuming Liu; Qian Li; Lingjuan Liao; Ruili Sun; Xueting Liu; Manli Jiang; Jinyue Hu
Journal:  Sci Rep       Date:  2015-12-09       Impact factor: 4.379

10.  Oligomannan Prebiotic Attenuates Immunological, Clinical and Behavioral Symptoms in Mouse Model of Inflammatory Bowel Disease.

Authors:  Szilamér Ferenczi; Krisztián Szegi; Zsuzsanna Winkler; Teréz Barna; Krisztina J Kovács
Journal:  Sci Rep       Date:  2016-09-23       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.